AstraZeneca's Global Initiative Surpasses 1 Million Lives Touched in the Fight Against Lung Cancer

Major Milestone Met in AI-Powered Fight Against Lung Cancer Global initiative gains significant ground in digitally identifying cancer risk before s...

November 22, 2023 | Wednesday | News
Mass General Brigham's Genetic Disease Center Launches Global Genomic Medicine Training in UAE

Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one size fits all'...

November 21, 2023 | Tuesday | News
SciSparc Celebrates Major Breakthrough with Positive Results Demonstrating Remarkable Impact on Alzheimer's Agitation in Treatment

SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central...

November 16, 2023 | Thursday | News
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program

Royalty Pharma to provide R&D funding support of up to $125 million for the development of olanzapine LAI (TEV-‘749), a long-acting subcutaneou...

November 14, 2023 | Tuesday | News
Africa CDC Director General Visits SK bioscience to Discuss Vaccine Localization in Africa

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience t...

November 06, 2023 | Monday | News
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics

Novogene is a leading provider of genomic services and solutions offering extensive next generation sequencing (NGS) capacity and bioinformatics expertise....

November 06, 2023 | Monday | News
IQVIA to Deliver its Orchestrated Customer Engagement (OCE) Platform to Sanofi in the Africa & Middle East Region

IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and bro...

October 24, 2023 | Tuesday | News
Teva Pharmaceuticals CEO Richard Francis Condemns Attacks on Israeli Civilians

Since the early hours of Saturday, Israel has witnessed a massive and horrifying assault on innocent lives, leaving hundreds dead, hundreds more injured, a...

October 09, 2023 | Monday | News
Unearthing the Oasis of Discovery: The Rising Tide of Life Sciences in the Middle East

Historical Perspective Traditionally, the Middle East's economy has been heavily reliant on its vast reserves of oil and natural gas. However, the region'...

October 06, 2023 | Friday | Analysis
Israel's SciSparc Initiates Clinical Trial of SCI-210 for Autism in Pediatrics

The study will evaluate the safety, tolerability, and efficacy of SCI-210, in comparison to CBD monotherapy in treating ASD. Designed as a randomized, doub...

October 02, 2023 | Monday | News
NeuroSense Granted Patents in Europe, Japan, and Israel for its ALS Drug PrimeC

Patents valid through 2038 Clinical topline results from Phase 2b ALS trial expected in H2 2023 Corresponding patents have b...

September 21, 2023 | Thursday | News
AHF Slams Johnson & Johnson for Immoral Profiteering on TB Treatment

“While shocking, this move by Johnson & Johnson is unfortunately not surprising – we demand that the company halt its profiteering tactics ...

September 20, 2023 | Wednesday | News
Revolutionizing Hyperbaric Oxygen Therapy: BARIKS Unveils Game-Changing Portable Chambers

In an exclusive interview with Yoav Blat, BARIKS' Representative in North America, we explore the technology behind this chamber and its potential to revol...

September 11, 2023 | Monday | News
Clearmind Medicine Collaborates with Johns Hopkins to Study CMND-100 for Alcohol Use Disorder

The principal investigator, Jennifer Ellis, PhD, Associate Professor of Psychiatry and Behavioral Sciences, JHU School of Medicine will be supported by co-...

September 07, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close